Controversy Over Banning Flavored Tobacco Products in Columbus Council Meeting

Nov.09.2022
Controversy Over Banning Flavored Tobacco Products in Columbus Council Meeting
Columbus officials debate banning flavored tobacco products due to racial disparities in tobacco marketing and high related health issues.

A heated debate took place at the Columbus City Council meeting on Wednesday between small business owners and public health advocates over the decision to ban menthol and flavored tobacco products. The call for a ban on menthol in Columbus has been growing since a study by the Columbus Public Health department revealed that disproportionate numbers of tobacco retailers are located in impoverished minority communities. These areas also have higher rates of smoking-related illnesses, such as stroke, chronic obstructive pulmonary disease, and asthma.


However, e-cigarette shop owners have issued warnings that implementing the ban could result in decreased sales and potential economic losses. There was no vote on the matter, and another city hall meeting is scheduled for late November.


1. Arguments for the Ban on Menthol Cigarettes 2. The Racist History Behind Menthol Cigarettes 3. Is the Ban on Menthol Cigarettes Effective? 4. Conclusion: Why We Should Ban Menthol Cigarettes.


People are calling on the Columbus City Council to ban the sale of menthol cigarettes and flavored e-cigarettes in stores. This argument was presented at a city council meeting on Wednesday in Columbus. According to research conducted by the Columbus Department of Public Health, this is a familiar point of contention.


Most tobacco retailers are located in urban areas where the Black population makes up 25% or more of the population. These same areas also have the highest cases of asthma in the city. In contrast, tobacco retailers are less common in higher income areas where there are fewer cases of smoking-related illnesses such as asthma and chronic obstructive pulmonary disease.


An alliance calling for a ban on the sale of menthol and other flavored tobacco products includes city leaders, the head of the Young Men's Christian Association, and the African American Tobacco Control Leadership Council led by Dr. Phillip Gardiner. Gardiner believes that the tobacco industry has exploited poor urban communities through racially targeted marketing practices.


He cited statistical data from several studies conducted over the years, which demonstrate:


In the United States, the number of black women who smoke menthol cigarettes or menthol-flavored tobacco increased from 5% in the 1950s to 42% in the 1970s, accounting for 85% of all black female smokers. Quitting smoking is harder for black smokers who use menthol products than those who use regular cigarettes.


According to Amanda Turner, the Executive Director of Tobacco 21:


Research suggests that if you are using menthol cigarettes and want to quit smoking by switching to regular cigarettes, your chances of successfully quitting may be increased. This is because menthol is a flavoring agent that provides a cooling sensation and can suppress coughing.


Source: Vaping Daily. Is peppermint-flavored vape discriminatory? Is creating peppermint-flavored vape products discriminatory toward certain racial or ethnic groups? This is the question being raised by Vaping Daily.


Though cigarettes themselves aren't racist, the tobacco industry's history of racism towards Black and minority smokers is well-documented. In the 1950s, Big Tobacco began targeting Black communities with menthol cigarettes, knowing they were more addictive than regular cigarettes. The industry found success with advertising campaigns aimed at minority communities.


More black individuals are taking up smoking, and as a result, more are dying. Even today, the Centers for Disease Control and Prevention reports that black (non-Hispanic) individuals make up 14.4% of all smokers in the United States, a higher percentage than white individuals, but lower than American Indian and Alaska Native populations. However, due to better education on cigarettes and community-sponsored quit-smoking programs, the proportion of black smokers has been decreasing over the years.


Is the peppermint oil ban effective?


During Wednesday's meeting, Dr. Gardiner cited situations in numerous cities and municipalities throughout the country where the sale of mint-flavored cigarettes has been banned. Additionally, 35 countries have also prohibited the use of menthol. Dr. Gardiner used Canada as an example to demonstrate the success of a menthol ban.


In 2015, Canada banned the sale of menthol cigarettes. A study conducted in 2018 found that this ban has had a significant impact on smoking habits. The study revealed that menthol cigarette smokers were more likely to quit smoking compared to regular cigarette smokers. Furthermore, the study predicted that the menthol ban in the US would result in 789,724 people quitting smoking every day.


Conclusion: Will a ban be put in place?


At Wednesday's meeting, many owners of e-cigarette programs expressed concern that the ban on mint-flavored e-cigarettes would harm their business. Other opponents of the ban argued that it would discriminate against Black people and adults who prefer mint flavors. Some attendees even mentioned that e-cigarettes and other flavored products could help smokers quit.


Dr. Gardner and other public health advocates stated that while these arguments are valid, they do not outweigh the positive effects of the ban. They referenced research from Canada, including a recent study that recommended the federal prohibition of menthol and other flavored products.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry exchange and research.


Due to limitations in translation skills, the translated article may not fully express the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any statements or positions related to domestic issues, as well as those involving Hong Kong, Macau, Taiwan, and foreign affairs.


Copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14